亞瑟斯抑制素A品管液:\nQC1:Recombinant human inhibin A at a level of approximately 150 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\nQC2:Recombinant human inhibin A at a level of approximately 400 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\nQC3:Recombinant human inhibin A at a level of approximately 800 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\n
共有 1 個藥物證書使用此成份
- 申請商
- 美商貝克曼庫爾特有限公司台灣分公司
- 適應症
- 含量
- 發證日期
- 2007-07-23